Literature DB >> 27668636

Descemet's Membrane Detachment with Schisis Induced by Phacoemulsification.

Wenjia Xie1, Yesheng Xu, Yu-Feng Yao.   

Abstract

PURPOSE: To describe a case of Descemet's membrane detachment and schisis (Descemet's membrane separated into multiple layers) with confirmation by high-definition anterior segment optical coherence tomography (AS-OCT) after phacoemulsification and intraocular lens implantation. CASE REPORT: A 72-year-old woman presented with persistent corneal edema after phacoemulsification. She was diagnosed with herpes simplex keratitis and had been unsuccessfully treated for 60 days in her local hospital. Slit-lamp examination revealed moderate conjunctival injection, disciform-like stromal edema, and diffuse superficial punctate epithelial erosions. Descemet's membrane schisis and detachment with an interlayer tear were verified by high-definition AS-OCT. After 2 weeks of medication with topical 0.1% fluorometholone eye drops four times daily together with 3% ofloxacin eye ointment twice daily, Descemet's membrane was reattached with complete resolution of conjunctival injection, corneal edema, and epithelial erosions.
CONCLUSIONS: This is a report of Descemet's membrane schisis in vivo that is documented and confirmed by high-definition AS-OCT. Descemet's membrane detachment and schisis caused by phacoemulsification can be misdiagnosed as herpetic keratitis due to stromal edema and epithelial erosion. Topical steroid and lubrication may help reattach Descemet's membrane to its original position.

Entities:  

Mesh:

Year:  2016        PMID: 27668636     DOI: 10.1097/OPX.0000000000000993

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  1 in total

1.  Incidence of Incision-Related Descemet Membrane Detachment Using Phacoemulsification With Trapezoid vs Conventional 2.2-mm Clear Corneal Incision: A Randomized Clinical Trial.

Authors:  Ye Dai; Zhenzhen Liu; Wei Wang; Xiaotong Han; Ling Jin; Xiaoyun Chen; Guangming Jin; Lanhua Wang; Enen Zhang; Bo Qu; Jianping Liu; Nathan Congdon; Mingguang He; Lixia Luo; Yizhi Liu
Journal:  JAMA Ophthalmol       Date:  2021-11-01       Impact factor: 8.253

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.